[HTML][HTML] Multiple sclerosis: current pathophysiological concepts

DM Wingerchuk, CF Lucchinetti, JH Noseworthy - Laboratory investigation, 2001 - Elsevier
Multiple sclerosis (MS) is an often disabling disease primarily affecting young adults that
exhibits extraordinary clinical, radiological, and pathological heterogeneity. We review the …

Role of oligodendrocyte dysfunction in demyelination, remyelination and neurodegeneration in multiple sclerosis

AO Dulamea - Multiple Sclerosis: Bench to Bedside: Global …, 2017 - Springer
Oligodendrocytes (OLs) are the myelinating cells of the central nervous system (CNS) during
development and throughout adulthood. They result from a complex and well controlled …

Magnetization transfer changes in the normal appering white matter precede the appearance of enhancing lesions in patients with multiple sclerosis

M Filippi, MA Rocca, G Martino… - Annals of …, 1998 - Wiley Online Library
Serial monthly magenetization transfer (MT) imaging was performed to evaluate whether a
change of the normal appearing white matter (NAWM), which precedes the appearance of …

The pathogenesis of lesions and normal-appearing white matter changes in multiple sclerosis: a serial diffusion MRI study

DJ Werring, D Brassat, AG Droogan, CA Clark… - Brain, 2000 - academic.oup.com
The idea that the initiating event in the formation of all new multiple sclerosis lesions is a
focal blood–brain barrier (BBB) leakage associated with perivascular inflammation has been …

Open-ring imaging sign: highly specific for atypical brain demyelination

JC Masdeu, C Quinto, C Olivera, M Tenner, D Leslie… - Neurology, 2000 - AAN Enterprises
Objective: To test the specificity for demyelination of a new neuroimaging sign: contrast
enhancement shaped as an open ring or a crescent circumscribed to the white matter …

Oral fumaric acid esters for the treatment of active multiple sclerosis: an open‐label, baseline‐controlled pilot study

S Schimrigk, N Brune, K Hellwig… - European journal of …, 2006 - Wiley Online Library
An exploratory, prospective, open‐label study of fumaric acid esters (FAE, Fumaderm®) was
conducted in patients with relapsing–remitting multiple sclerosis (RRMS). The study …

Efficacy of treatment of MS with IFNβ-1b or glatiramer acetate by monthly brain MRI in the BECOME study

D Cadavid, LJ Wolansky, J Skurnick, J Lincoln… - Neurology, 2009 - AAN Enterprises
Background: There are no published MRI studies comparing interferon beta 1b (IFNβ-1b)
and glatiramer acetate (GA) for treatment of relapsing multiple sclerosis (MS). Objective: To …

Albumin and multiple sclerosis

SM LeVine - BMC neurology, 2016 - Springer
Leakage of the blood–brain barrier (BBB) is a common pathological feature in multiple
sclerosis (MS). Following a breach of the BBB, albumin, the most abundant protein in …

Persistent endothelial abnormalities and blood–brain barrier leak in primary and secondary progressive multiple sclerosis

S Leech, J Kirk, J Plumb… - … and applied neurobiology, 2007 - Wiley Online Library
Epithelial and endothelial tight junctions are pathologically altered in infectious,
inflammatory, neoplastic and other diseases. Previously, we described such abnormalities …

Quantification of perfusion and permeability in multiple sclerosis: dynamic contrast-enhanced MRI in 3D at 3T

M Ingrisch, S Sourbron, D Morhard… - Investigative …, 2012 - journals.lww.com
Background and Purpose: The quantification of cerebral blood flow (CBF), cerebral blood
volume (CBV), and blood-brain barrier permeability in scattered lesions in the brain is a …